Journal
ADVANCED HEALTHCARE MATERIALS
Volume 12, Issue 5, Pages -Publisher
WILEY
DOI: 10.1002/adhm.202202085
Keywords
activatable photodynamic immunotherapy; immune checkpoint blockades; immunogenic cell death; near-infrared photosensitizers
Ask authors/readers for more resources
Combining photodynamic therapy (PDT) with immune checkpoint blockades can enhance immunotherapeutic outcomes in cancer treatment. However, the continuous bioactivity of photosensitizers and immune checkpoint inhibitors can lead to uncontrollable side effects. This study develops an activatable photodynamic immunomodulator to improve selectivity and achieve effective cancer therapy.
Combining photodynamic therapy (PDT) and immune checkpoint blockades is an efficient method to maximize immunotherapeutic outcome by boosting tumor immunogenicity and modulating the immunosuppressive tumor microenvironment. However, the always-on bioactivity of photosensitizers or immune checkpoint inhibitors leads to uncontrollable side effects, limiting the in vivo therapeutic efficacy of treatments. An activatable strategy is of great importance for improving the selectivity during cancer therapy. In this study, a photodynamic immunomodulator, ICy-NLG, is developed by conjugating the photosensitizer ICy-NH2 with the indoleamine 2,3-dioxygenase 1 inhibitor NLG919 through a glutathione (GSH)-cleavable linker to achieve activatable photodynamic immunotherapy. The conjugation considerably suppresses both the PDT effect and the activity of the inhibitor. After ICy-NLG is activated by high levels of GSH in tumor cells, the PDT effect is restored and leads to immunogenic tumor cell death. The released tumor-associated antigens in conjunction with the activated immune checkpoint inhibitor induce a synergistic antitumor immune response, resulting in the growth inhibition of primary and distant tumors and the prevention of lung metastasis in mouse xenograft models.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available